Piribedil | List of Frontiers open access articles

Systematic Review

Published on 16 Jun 2023

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis

in Movement Disorders

Xiang-Ting Chen
Qian Zhang
Fei-Fei Chen
Si-Yuan Wen
Chang-Qing Zhou

Frontiers in Neurology

doi 10.3389/fneur.2023.1183823

7,703 views
10 citations

Original Research

Published on 01 Dec 2014

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation

in Cellular Neurophysiology

Lais S. Rodrigues
Adriano D. S. Targa
Ana Carolina D. Noseda
Mariana F. Aurich
Cláudio Da Cunha
Marcelo M. S. Lima

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2014.00383

7,575 views
47 citations

Review

Published on 14 Nov 2018

The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer

in Cancer Molecular Targets and Therapeutics

Kebin Lu
He Tao
Xiaomin Si
Qingjuan Chen

Frontiers in Oncology

doi 10.3389/fonc.2018.00502

20,105 views
76 citations

Case Report

Published on 09 Oct 2025

Remarkable therapeutic effects of methylphenidate in periodic limb movement disorder comorbid with excessive daytime sleepiness: a case report

in Sleep and Circadian Rhythms

Jiafeng Ren
Xinyan Zhang
Junying Zhou
Liu Liu

Frontiers in Neuroscience

doi 10.3389/fnins.2025.1659120

2,402 views

Original Research

Published on 17 Dec 2025

Rapid health technology assessment of six non-ergot dopamine-receptor agonists for the treatment of early Parkinson’s disease

in Drugs Outcomes Research and Policies

Jieqiong Lv
Hongbo Fu
Yanqiong Zhou
Wenwei Li
Jiaxin Zhang
Zhihua Zhou
Sha Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1648833

1,183 views

Original Research

Published on 25 Mar 2025

Multigenetic pharmacogenomics–guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson’s disease: a small real-word prospective cohort study

in Pharmacogenetics and Pharmacogenomics

Yifan Li
Mao Li
Miao Wang
Jiarui Yao
Fengzhu Li
Siyu Chen
Xi Yin
Zhongbao Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1502379

2,171 views
1 citation

Articles

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation

The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer

Remarkable therapeutic effects of methylphenidate in periodic limb movement disorder comorbid with excessive daytime sleepiness: a case report

Rapid health technology assessment of six non-ergot dopamine-receptor agonists for the treatment of early Parkinson’s disease

Multigenetic pharmacogenomics–guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson’s disease: a small real-word prospective cohort study